187 related articles for article (PubMed ID: 38326712)
1. Usefulness of fluorescent ureteral navigation in total pelvic exenteration using a two-team approach for locally recurrent pelvic malignancies-A video vignette.
Ogura A; Murata Y; Jinno T; Yoshikawa N; Kajiyama H; Ebata T
Colorectal Dis; 2024 Apr; 26(4):812-813. PubMed ID: 38326712
[No Abstract] [Full Text] [Related]
2. Total pelvic exenteration with preservation of fecal continence.
Brodsky JT; Sloane BB; Khanna OP
J Surg Oncol; 1993 Aug; 53(4):261-4. PubMed ID: 8341059
[TBL] [Abstract][Full Text] [Related]
3. [Total pelvic exenteration for invasive tumors of the pelvis].
Gertsch P; Preitner J; Pettavel J; Mosimann R
Helv Chir Acta; 1984 Apr; 51(1):75-8. PubMed ID: 6724986
[No Abstract] [Full Text] [Related]
4. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
5. [Pelvic exenteration--indications, radical nature and follow-up demonstrated with 33 clinical cases].
Kolbert G; Müller G; Kujath P; Bruch HP
Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1096-7. PubMed ID: 9574344
[TBL] [Abstract][Full Text] [Related]
6. Laparoscopic Anterior Pelvic Exenteration with Super Radical Parametrectomy for a Recurrent Low-Grade Endometrial Sarcoma That is Resistant to Hormone Therapy and Chemotherapy.
Kanao H; Hisa T; Omi M; Nagashima M; Okamoto S; Aoki Y; Tanigawa T; Matoda M; Okamoto S; Nomura H; Omatsu K; Kato K; Utsugi K; Takeshima N
J Minim Invasive Gynecol; 2019 Jan; 26(1):34-35. PubMed ID: 29621612
[TBL] [Abstract][Full Text] [Related]
7. The place of pelvic exenteration in surgical management of advanced and recurrent pelvic tumors.
D'Addato F; Guercio E; Re A; Gatti M; Raspollini M; Proserpio D; Bellino R; Lanza A
Eur J Gynaecol Oncol; 1988; 9(5):420-3. PubMed ID: 3224613
[TBL] [Abstract][Full Text] [Related]
8. Total laparoscopic pelvic exenteration for a laterally recurrent cervical carcinoma with a vesicovaginal fistula that developed after concurrent chemoradiotherapy.
Kanao H; Aoki Y; Hisa T; Takeshima N
Gynecol Oncol; 2017 Aug; 146(2):438-439. PubMed ID: 28576262
[TBL] [Abstract][Full Text] [Related]
9. Management of advanced pelvic cancer by exenteration.
Kecmanovic DM; Pavlov MJ; Kovacevic PA; Sepetkovski AV; Ceranic MS; Stamenkovic AB
Eur J Surg Oncol; 2003 Nov; 29(9):743-6. PubMed ID: 14602493
[TBL] [Abstract][Full Text] [Related]
10. [Total pelvic exenteration].
Heger U; Koch M; Büchler MW; Weitz J
Chirurg; 2010 Oct; 81(10):897-901. PubMed ID: 20835694
[TBL] [Abstract][Full Text] [Related]
11. Pelvic Exenteration Surgery: The Evolution of Radical Surgical Techniques for Advanced and Recurrent Pelvic Malignancy.
Brown KGM; Solomon MJ; Koh CE
Dis Colon Rectum; 2017 Jul; 60(7):745-754. PubMed ID: 28594725
[TBL] [Abstract][Full Text] [Related]
12. [Plastic surgery of extended defects after exenteration of the pelvis].
Abdou A; Bruns H; Troja A; Antolovic D; Li L; Raab HR
Zentralbl Chir; 2015 Apr; 140(2):214-8. PubMed ID: 25874472
[TBL] [Abstract][Full Text] [Related]
13. Pelvic exenteration for advanced pelvic malignancies.
Yu HH; Leong CH; Ong GB
Aust N Z J Surg; 1976 Aug; 46(3):197-201. PubMed ID: 1070292
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic pelvic exenteration for advanced pelvic cancers: a review of 16 cases.
Puntambekar S; Kudchadkar RJ; Gurjar AM; Sathe RM; Chaudhari YC; Agarwal GA; Rayate NV
Gynecol Oncol; 2006 Sep; 102(3):513-6. PubMed ID: 16510172
[TBL] [Abstract][Full Text] [Related]
15. The role of pelvic exenteration for sarcomatous malignancies.
Reid GC; Morley GW; Schmidt RW; Hopkins MP
Obstet Gynecol; 1989 Jul; 74(1):80-4. PubMed ID: 2733946
[TBL] [Abstract][Full Text] [Related]
16. [Recurrences of pelvic cancers. Pelvic reconstruction: when, how, why?].
Houvenaeghel G; Moutardier V; Bladou F; Zalta R
Ann Chir; 1999; 53(9):902-4. PubMed ID: 10633940
[No Abstract] [Full Text] [Related]
17. Cystoprostatectomy versus prostatectomy alone for locally advanced or recurrent pelvic cancer.
Turner GA; Harris CA; Eglinton TW; Wakeman CJ; Kueppers F; Dixon L; Dobbs BR; Frizelle FA
ANZ J Surg; 2016; 86(1-2):54-8. PubMed ID: 25113257
[TBL] [Abstract][Full Text] [Related]
18. Total pelvic exenteration for the treatment of advanced primary or recurrent pelvic neoplasia.
Carballo L; Enríquez-Navascués JM; Saralegui Y; Placer C; Timoteo A; Borda N; Carrillo A; Sainz-Lete A
Cir Esp; 2015 Mar; 93(3):174-80. PubMed ID: 25443154
[TBL] [Abstract][Full Text] [Related]
19. Urological outcomes following pelvic exenteration for advanced pelvic cancer are not inferior to those following radical cystectomy.
Aslim EJ; Chew MH; Chew GK; Lee LS
ANZ J Surg; 2018 Sep; 88(9):896-900. PubMed ID: 29895098
[TBL] [Abstract][Full Text] [Related]
20. Pelvic exenteration with rectal resection for different types of malignancies at two tertiary referral centres.
Garcia-Granero A; Biondo S; Espin-Basany E; González-Castillo A; Valverde S; Trenti L; Gil-Moreno A; Kreisler E
Cir Esp (Engl Ed); 2018 Mar; 96(3):138-148. PubMed ID: 29229359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
